Clinical Trials for Enliven Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Enliven Therapeutics

Clinical Trials (4)

NCT06787144
ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants
PHASE1Recruiting
21 participants
Started: Jan 23, 2025 · Completed: Jan 31, 2028
2 conditions1 sponsor4 locations
NCT06328738
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
PHASE1Active, not recruiting
275 participants
Started: May 30, 2024 · Completed: Jul 31, 2028
5 conditions1 sponsor31 locations
NCT05650879
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
PHASE1Active, not recruiting
198 participants
Started: Mar 20, 2023 · Completed: Jul 31, 2026
4 conditions1 sponsor39 locations
NCT05304377
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
PHASE1Recruiting
200 participants
Started: May 22, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor46 locations